Reference : Oral ibandronate (150 mg) continues to be effective and well tolerated when administe...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Endocrinology, metabolism & nutrition
Human health sciences : Public health, health care sciences & services
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/81405
Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study long-term extension
English
Stakkestad, J. A. [ > > ]
Lorenc, R. [ > > ]
Czerwinski, E. [ > > ]
Sedarati, F. [ > > ]
Neate, C. [ > > ]
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Mar-2007
Osteoporosis International
Springer Science & Business Media B.V.
18
Suppl.1
S135-136
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Godalming
United Kingdom
Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
du 28 mars 2007 au 31 mars 2007
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liège, Belgium and ESCEO
Porto
Portugal
http://hdl.handle.net/2268/81405

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
P321.pdfPublisher postprint233.95 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.